Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$144.95 - $152.29 $1.33 Million - $1.4 Million
9,179 Added 631.73%
10,632 $1.61 Million
Q2 2022

Aug 10, 2022

SELL
$83.14 - $145.99 $43,565 - $76,498
-524 Reduced 26.5%
1,453 $212,000
Q1 2022

Apr 21, 2022

BUY
$110.08 - $142.92 $217,628 - $282,552
1,977 New
1,977 $234,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.